Retatrutide is an experimental triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon pathways, designed for weight management and type 2 diabetes. It helps reduce appetite and improve metabolic health by mimicking natural hormones. Benefits primarily adults with obesity or overweight conditions seeking enhanced glucose control and significant, sustainable weight loss under medical supervision.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends